nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—Stridor—Riluzole—amyotrophic lateral sclerosis	0.0193	0.052	CcSEcCtD
Sevoflurane—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0455	CcSEcCtD
Sevoflurane—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0306	CcSEcCtD
Sevoflurane—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0303	CcSEcCtD
Sevoflurane—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0303	CcSEcCtD
Sevoflurane—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0288	CcSEcCtD
Sevoflurane—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0267	CcSEcCtD
Sevoflurane—GABRQ—nerve—amyotrophic lateral sclerosis	0.00927	0.0318	CbGeAlD
Sevoflurane—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00914	0.0246	CcSEcCtD
Sevoflurane—KCNK10—hindbrain—amyotrophic lateral sclerosis	0.00863	0.0296	CbGeAlD
Sevoflurane—KCNK9—hindbrain—amyotrophic lateral sclerosis	0.00858	0.0294	CbGeAlD
Sevoflurane—GRIA1—nerve—amyotrophic lateral sclerosis	0.00838	0.0288	CbGeAlD
Sevoflurane—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00836	0.0225	CcSEcCtD
Sevoflurane—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00836	0.0225	CcSEcCtD
Sevoflurane—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00822	0.0221	CcSEcCtD
Sevoflurane—KCNA1—nerve—amyotrophic lateral sclerosis	0.00818	0.0281	CbGeAlD
Sevoflurane—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00815	0.022	CcSEcCtD
Sevoflurane—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00777	0.0209	CcSEcCtD
Sevoflurane—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00742	0.02	CcSEcCtD
Sevoflurane—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00697	0.0188	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00697	0.0188	CcSEcCtD
Sevoflurane—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00687	0.0185	CcSEcCtD
Sevoflurane—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00669	0.018	CcSEcCtD
Sevoflurane—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0173	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00629	0.017	CcSEcCtD
Sevoflurane—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00629	0.017	CcSEcCtD
Sevoflurane—GRIA1—hindbrain—amyotrophic lateral sclerosis	0.00628	0.0216	CbGeAlD
Sevoflurane—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00622	0.0168	CcSEcCtD
Sevoflurane—KCNA1—hindbrain—amyotrophic lateral sclerosis	0.00613	0.021	CbGeAlD
Sevoflurane—ATP2C1—nerve—amyotrophic lateral sclerosis	0.00573	0.0197	CbGeAlD
Sevoflurane—KCNK18—spinal cord—amyotrophic lateral sclerosis	0.00553	0.019	CbGeAlD
Sevoflurane—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00552	0.0149	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00523	0.0141	CcSEcCtD
Sevoflurane—KCNK10—brainstem—amyotrophic lateral sclerosis	0.00495	0.017	CbGeAlD
Sevoflurane—KCNK9—brainstem—amyotrophic lateral sclerosis	0.00492	0.0169	CbGeAlD
Sevoflurane—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00482	0.013	CcSEcCtD
Sevoflurane—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00482	0.0165	CbGeAlD
Sevoflurane—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00472	0.0127	CcSEcCtD
Sevoflurane—KCNK18—nervous system—amyotrophic lateral sclerosis	0.00466	0.016	CbGeAlD
Sevoflurane—KCNK18—central nervous system—amyotrophic lateral sclerosis	0.00449	0.0154	CbGeAlD
Sevoflurane—ATP5D—hindbrain—amyotrophic lateral sclerosis	0.00435	0.0149	CbGeAlD
Sevoflurane—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0117	CcSEcCtD
Sevoflurane—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0117	CcSEcCtD
Sevoflurane—GLRA1—nervous system—amyotrophic lateral sclerosis	0.00433	0.0149	CbGeAlD
Sevoflurane—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00422	0.0114	CcSEcCtD
Sevoflurane—GLRA1—central nervous system—amyotrophic lateral sclerosis	0.00417	0.0143	CbGeAlD
Sevoflurane—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00387	0.0104	CcSEcCtD
Sevoflurane—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00995	CcSEcCtD
Sevoflurane—GRIA1—brainstem—amyotrophic lateral sclerosis	0.0036	0.0124	CbGeAlD
Sevoflurane—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00355	0.0122	CbGeAlD
Sevoflurane—KCNA1—brainstem—amyotrophic lateral sclerosis	0.00351	0.0121	CbGeAlD
Sevoflurane—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00925	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00897	CcSEcCtD
Sevoflurane—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00324	0.0111	CbGeAlD
Sevoflurane—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00867	CcSEcCtD
Sevoflurane—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00856	CcSEcCtD
Sevoflurane—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00852	CcSEcCtD
Sevoflurane—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00852	CcSEcCtD
Sevoflurane—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00845	CcSEcCtD
Sevoflurane—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00313	0.0108	CbGeAlD
Sevoflurane—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00841	CcSEcCtD
Sevoflurane—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00835	CcSEcCtD
Sevoflurane—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00293	0.0079	CcSEcCtD
Sevoflurane—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00773	CcSEcCtD
Sevoflurane—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00769	CcSEcCtD
Sevoflurane—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00768	CcSEcCtD
Sevoflurane—Chills—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00764	CcSEcCtD
Sevoflurane—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00761	CcSEcCtD
Sevoflurane—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00746	CcSEcCtD
Sevoflurane—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00276	0.00948	CbGeAlD
Sevoflurane—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00741	CcSEcCtD
Sevoflurane—Tension—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00728	CcSEcCtD
Sevoflurane—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00726	CcSEcCtD
Sevoflurane—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0072	CcSEcCtD
Sevoflurane—KCNK10—nervous system—amyotrophic lateral sclerosis	0.00259	0.0089	CbGeAlD
Sevoflurane—KCNK9—nervous system—amyotrophic lateral sclerosis	0.00258	0.00884	CbGeAlD
Sevoflurane—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00681	CcSEcCtD
Sevoflurane—GRIA1—medulla oblongata—amyotrophic lateral sclerosis	0.00251	0.00861	CbGeAlD
Sevoflurane—KCNK10—central nervous system—amyotrophic lateral sclerosis	0.0025	0.00856	CbGeAlD
Sevoflurane—ATP5D—brainstem—amyotrophic lateral sclerosis	0.00249	0.00856	CbGeAlD
Sevoflurane—KCNK9—central nervous system—amyotrophic lateral sclerosis	0.00248	0.00851	CbGeAlD
Sevoflurane—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00665	CcSEcCtD
Sevoflurane—KCNK10—cerebellum—amyotrophic lateral sclerosis	0.00244	0.00837	CbGeAlD
Sevoflurane—KCNK9—cerebellum—amyotrophic lateral sclerosis	0.00242	0.00832	CbGeAlD
Sevoflurane—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00652	CcSEcCtD
Sevoflurane—Cough—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00647	CcSEcCtD
Sevoflurane—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00642	CcSEcCtD
Sevoflurane—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0064	CcSEcCtD
Sevoflurane—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00631	CcSEcCtD
Sevoflurane—KCNK3—nervous system—amyotrophic lateral sclerosis	0.00234	0.00803	CbGeAlD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00627	CcSEcCtD
Sevoflurane—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00617	CcSEcCtD
Sevoflurane—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0061	CcSEcCtD
Sevoflurane—KCNK3—central nervous system—amyotrophic lateral sclerosis	0.00225	0.00773	CbGeAlD
Sevoflurane—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00605	CcSEcCtD
Sevoflurane—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00605	CcSEcCtD
Sevoflurane—GRIA1—spinal cord—amyotrophic lateral sclerosis	0.00224	0.00768	CbGeAlD
Sevoflurane—Shock—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00595	CcSEcCtD
Sevoflurane—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00593	CcSEcCtD
Sevoflurane—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00592	CcSEcCtD
Sevoflurane—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00591	CcSEcCtD
Sevoflurane—KCNA1—spinal cord—amyotrophic lateral sclerosis	0.00218	0.0075	CbGeAlD
Sevoflurane—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00588	CcSEcCtD
Sevoflurane—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00565	CcSEcCtD
Sevoflurane—GABRQ—nervous system—amyotrophic lateral sclerosis	0.00208	0.00716	CbGeAlD
Sevoflurane—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00203	0.00698	CbGeAlD
Sevoflurane—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00547	CcSEcCtD
Sevoflurane—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00201	0.00691	CbGeAlD
Sevoflurane—GABRQ—central nervous system—amyotrophic lateral sclerosis	0.00201	0.00689	CbGeAlD
Sevoflurane—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.002	0.00539	CcSEcCtD
Sevoflurane—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.002	0.00538	CcSEcCtD
Sevoflurane—KCNK10—brain—amyotrophic lateral sclerosis	0.00198	0.0068	CbGeAlD
Sevoflurane—KCNK9—brain—amyotrophic lateral sclerosis	0.00197	0.00676	CbGeAlD
Sevoflurane—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00522	CcSEcCtD
Sevoflurane—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00194	0.00665	CbGeAlD
Sevoflurane—Pain—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00517	CcSEcCtD
Sevoflurane—GRIA1—nervous system—amyotrophic lateral sclerosis	0.00189	0.00647	CbGeAlD
Sevoflurane—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.00188	0.00645	CbGeAlD
Sevoflurane—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00186	0.00638	CbGeAlD
Sevoflurane—KCNK2—brain—amyotrophic lateral sclerosis	0.00185	0.00635	CbGeAlD
Sevoflurane—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00499	CcSEcCtD
Sevoflurane—KCNA1—nervous system—amyotrophic lateral sclerosis	0.00184	0.00632	CbGeAlD
Sevoflurane—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00183	0.00627	CbGeAlD
Sevoflurane—GRIA1—central nervous system—amyotrophic lateral sclerosis	0.00182	0.00623	CbGeAlD
Sevoflurane—GABRA1—brainstem—amyotrophic lateral sclerosis	0.0018	0.00616	CbGeAlD
Sevoflurane—KCNK3—brain—amyotrophic lateral sclerosis	0.00179	0.00614	CbGeAlD
Sevoflurane—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00481	CcSEcCtD
Sevoflurane—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00478	CcSEcCtD
Sevoflurane—GRIA1—cerebellum—amyotrophic lateral sclerosis	0.00177	0.00609	CbGeAlD
Sevoflurane—KCNA1—central nervous system—amyotrophic lateral sclerosis	0.00177	0.00608	CbGeAlD
Sevoflurane—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00176	0.00603	CbGeAlD
Sevoflurane—ATP5D—medulla oblongata—amyotrophic lateral sclerosis	0.00174	0.00597	CbGeAlD
Sevoflurane—KCNA1—cerebellum—amyotrophic lateral sclerosis	0.00173	0.00594	CbGeAlD
Sevoflurane—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.00173	0.00593	CbGeAlD
Sevoflurane—ATP2C1—medulla oblongata—amyotrophic lateral sclerosis	0.00172	0.00589	CbGeAlD
Sevoflurane—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00167	0.00575	CbGeAlD
Sevoflurane—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00446	CcSEcCtD
Sevoflurane—ND1—nervous system—amyotrophic lateral sclerosis	0.00162	0.00556	CbGeAlD
Sevoflurane—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00434	CcSEcCtD
Sevoflurane—GABRQ—brain—amyotrophic lateral sclerosis	0.00159	0.00547	CbGeAlD
Sevoflurane—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00428	CcSEcCtD
Sevoflurane—ND1—central nervous system—amyotrophic lateral sclerosis	0.00156	0.00536	CbGeAlD
Sevoflurane—ATP5D—spinal cord—amyotrophic lateral sclerosis	0.00155	0.00532	CbGeAlD
Sevoflurane—ATP2C1—spinal cord—amyotrophic lateral sclerosis	0.00153	0.00525	CbGeAlD
Sevoflurane—GABRD—nervous system—amyotrophic lateral sclerosis	0.00151	0.00519	CbGeAlD
Sevoflurane—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00148	0.004	CcSEcCtD
Sevoflurane—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00146	0.005	CbGeAlD
Sevoflurane—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00146	0.005	CbGeAlD
Sevoflurane—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00145	0.00497	CbGeAlD
Sevoflurane—GRIA1—brain—amyotrophic lateral sclerosis	0.00144	0.00495	CbGeAlD
Sevoflurane—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00385	CcSEcCtD
Sevoflurane—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00142	0.00488	CbGeAlD
Sevoflurane—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00142	0.00487	CbGeAlD
Sevoflurane—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00142	0.00487	CbGeAlD
Sevoflurane—Rash—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00382	CcSEcCtD
Sevoflurane—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00381	CcSEcCtD
Sevoflurane—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00141	0.00484	CbGeAlD
Sevoflurane—KCNA1—brain—amyotrophic lateral sclerosis	0.00141	0.00483	CbGeAlD
Sevoflurane—Headache—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00379	CcSEcCtD
Sevoflurane—GABRA5—nervous system—amyotrophic lateral sclerosis	0.0014	0.00482	CbGeAlD
Sevoflurane—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.0014	0.00481	CbGeAlD
Sevoflurane—GABRG3—brain—amyotrophic lateral sclerosis	0.0014	0.00479	CbGeAlD
Sevoflurane—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00478	CbGeAlD
Sevoflurane—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00137	0.0047	CbGeAlD
Sevoflurane—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.00136	0.00467	CbGeAlD
Sevoflurane—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00466	CbGeAlD
Sevoflurane—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00135	0.00464	CbGeAlD
Sevoflurane—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00359	CcSEcCtD
Sevoflurane—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00133	0.00456	CbGeAlD
Sevoflurane—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00131	0.00449	CbGeAlD
Sevoflurane—ATP5D—nervous system—amyotrophic lateral sclerosis	0.00131	0.00449	CbGeAlD
Sevoflurane—ATP2C1—nervous system—amyotrophic lateral sclerosis	0.00129	0.00443	CbGeAlD
Sevoflurane—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00127	0.00437	CbGeAlD
Sevoflurane—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00126	0.00434	CbGeAlD
Sevoflurane—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00126	0.00434	CbGeAlD
Sevoflurane—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00126	0.00432	CbGeAlD
Sevoflurane—ATP5D—central nervous system—amyotrophic lateral sclerosis	0.00126	0.00432	CbGeAlD
Sevoflurane—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00125	0.0043	CbGeAlD
Sevoflurane—ATP2C1—central nervous system—amyotrophic lateral sclerosis	0.00124	0.00426	CbGeAlD
Sevoflurane—ND1—brain—amyotrophic lateral sclerosis	0.00124	0.00425	CbGeAlD
Sevoflurane—ATP5D—cerebellum—amyotrophic lateral sclerosis	0.00123	0.00422	CbGeAlD
Sevoflurane—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00123	0.00421	CbGeAlD
Sevoflurane—ATP2C1—cerebellum—amyotrophic lateral sclerosis	0.00121	0.00417	CbGeAlD
Sevoflurane—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.0012	0.00411	CbGeAlD
Sevoflurane—GABRD—brain—amyotrophic lateral sclerosis	0.00116	0.00397	CbGeAlD
Sevoflurane—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00112	0.00383	CbGeAlD
Sevoflurane—GABRG1—brain—amyotrophic lateral sclerosis	0.00111	0.00382	CbGeAlD
Sevoflurane—GABRA6—brain—amyotrophic lateral sclerosis	0.00111	0.0038	CbGeAlD
Sevoflurane—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00109	0.00374	CbGeAlD
Sevoflurane—GABRB1—brain—amyotrophic lateral sclerosis	0.00108	0.0037	CbGeAlD
Sevoflurane—GABRA5—brain—amyotrophic lateral sclerosis	0.00107	0.00368	CbGeAlD
Sevoflurane—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00107	0.00366	CbGeAlD
Sevoflurane—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00107	0.00366	CbGeAlD
Sevoflurane—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.00104	0.00356	CbGeAlD
Sevoflurane—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00103	0.00352	CbGeAlD
Sevoflurane—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00103	0.00352	CbGeAlD
Sevoflurane—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.001	0.00344	CbGeAlD
Sevoflurane—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.001	0.00344	CbGeAlD
Sevoflurane—GABRA3—brain—amyotrophic lateral sclerosis	0.000999	0.00343	CbGeAlD
Sevoflurane—ATP5D—brain—amyotrophic lateral sclerosis	0.000999	0.00343	CbGeAlD
Sevoflurane—ATP2C1—brain—amyotrophic lateral sclerosis	0.000986	0.00338	CbGeAlD
Sevoflurane—GABRA4—brain—amyotrophic lateral sclerosis	0.000973	0.00334	CbGeAlD
Sevoflurane—GABRA2—nervous system—amyotrophic lateral sclerosis	0.000973	0.00334	CbGeAlD
Sevoflurane—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.000971	0.00333	CbGeAlD
Sevoflurane—GABRE—nervous system—amyotrophic lateral sclerosis	0.000965	0.00331	CbGeAlD
Sevoflurane—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000941	0.00323	CbGeAlD
Sevoflurane—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.000937	0.00322	CbGeAlD
Sevoflurane—GABRE—central nervous system—amyotrophic lateral sclerosis	0.000929	0.00319	CbGeAlD
Sevoflurane—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.000916	0.00314	CbGeAlD
Sevoflurane—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000906	0.00311	CbGeAlD
Sevoflurane—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.000885	0.00304	CbGeAlD
Sevoflurane—CYP2A6—brain—amyotrophic lateral sclerosis	0.000842	0.00289	CbGeAlD
Sevoflurane—GABRB3—nervous system—amyotrophic lateral sclerosis	0.000818	0.00281	CbGeAlD
Sevoflurane—GABRB2—brain—amyotrophic lateral sclerosis	0.000814	0.00279	CbGeAlD
Sevoflurane—GABRG2—brain—amyotrophic lateral sclerosis	0.000814	0.00279	CbGeAlD
Sevoflurane—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.000788	0.0027	CbGeAlD
Sevoflurane—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00077	0.00264	CbGeAlD
Sevoflurane—GABRA2—brain—amyotrophic lateral sclerosis	0.000744	0.00255	CbGeAlD
Sevoflurane—GABRE—brain—amyotrophic lateral sclerosis	0.000738	0.00253	CbGeAlD
Sevoflurane—GABRA1—brain—amyotrophic lateral sclerosis	0.000719	0.00247	CbGeAlD
Sevoflurane—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000693	0.00238	CbGeAlD
Sevoflurane—ALB—brain—amyotrophic lateral sclerosis	0.000672	0.00231	CbGeAlD
Sevoflurane—GABRB3—brain—amyotrophic lateral sclerosis	0.000625	0.00215	CbGeAlD
Sevoflurane—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000618	0.00212	CbGeAlD
Sevoflurane—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000555	0.0019	CbGeAlD
Sevoflurane—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000534	0.00183	CbGeAlD
Sevoflurane—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00052	0.00179	CbGeAlD
Sevoflurane—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000501	0.00172	CbGeAlD
Sevoflurane—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00049	0.00168	CbGeAlD
Sevoflurane—CYP2B6—brain—amyotrophic lateral sclerosis	0.000424	0.00146	CbGeAlD
Sevoflurane—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000419	0.00144	CbGeAlD
Sevoflurane—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000403	0.00138	CbGeAlD
Sevoflurane—CYP2E1—brain—amyotrophic lateral sclerosis	0.000398	0.00137	CbGeAlD
Sevoflurane—ATP5D—Metabolism—DAO—amyotrophic lateral sclerosis	0.000308	0.000913	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000308	0.000913	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000307	0.000908	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000306	0.000907	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000306	0.000907	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000305	0.000904	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000304	0.000901	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000304	0.000901	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000303	0.000898	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000301	0.000892	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000301	0.000892	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0003	0.00089	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000298	0.000882	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000297	0.000878	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000295	0.000875	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000293	0.000866	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000292	0.000865	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000292	0.000865	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000292	0.000865	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000287	0.000851	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000282	0.000836	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000282	0.000836	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000281	0.000831	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00028	0.000829	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00028	0.000829	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000276	0.000818	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000275	0.000816	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000275	0.000814	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000275	0.000814	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000273	0.000808	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000273	0.000807	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000272	0.000806	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000272	0.000806	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000269	0.000797	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000267	0.000791	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000267	0.000791	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000267	0.00079	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000264	0.000781	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000263	0.00078	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000263	0.000777	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000263	0.000777	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000262	0.000776	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000261	0.000772	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000261	0.000772	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00026	0.000771	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000258	0.000763	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000256	0.000758	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000256	0.000758	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000256	0.000758	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000255	0.000756	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000251	0.000744	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00025	0.000739	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000242	0.000718	CbGpPWpGaD
Sevoflurane—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000241	0.000715	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000241	0.000713	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000238	0.000705	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000234	0.000693	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000234	0.000693	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000234	0.000692	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000234	0.000692	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000232	0.000688	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000229	0.000678	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000228	0.000676	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000224	0.000663	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000224	0.000663	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000224	0.000662	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00022	0.00065	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000218	0.000644	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000217	0.000643	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000217	0.000643	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000216	0.000639	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSR—amyotrophic lateral sclerosis	0.000216	0.000639	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00021	0.000623	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000207	0.000614	CbGpPWpGaD
Sevoflurane—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000206	0.00061	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000203	0.000601	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0002	0.000591	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000196	0.000581	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000195	0.000578	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000194	0.000573	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000194	0.000573	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000192	0.000568	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000184	0.000546	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000183	0.000541	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000179	0.00053	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000179	0.00053	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000178	0.000526	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000177	0.000525	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000177	0.000525	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000177	0.000524	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000176	0.000522	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000176	0.000522	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000176	0.000521	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000174	0.000517	CbGpPWpGaD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000172	0.000511	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000172	0.000509	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00017	0.000504	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000169	0.0005	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000167	0.000494	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000167	0.000494	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000166	0.000492	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000165	0.000488	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000165	0.000487	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000165	0.000487	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000162	0.00048	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00016	0.000473	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000159	0.000472	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000159	0.000472	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000157	0.000465	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000151	0.000446	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000151	0.000446	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000149	0.000442	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000149	0.00044	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000148	0.000439	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000147	0.000434	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000146	0.000433	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000146	0.000433	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000145	0.00043	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000144	0.000425	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000144	0.000425	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000142	0.000419	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000141	0.000418	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000141	0.000418	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00014	0.000415	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00014	0.000415	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000139	0.000413	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000138	0.000408	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000138	0.000408	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000136	0.000401	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000134	0.000397	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00013	0.000386	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000128	0.000379	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000126	0.000373	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000126	0.000372	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000125	0.00037	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000123	0.000363	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000122	0.000362	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000121	0.000358	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00012	0.000357	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00012	0.000356	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00012	0.000356	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000119	0.000352	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000118	0.000349	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000117	0.000346	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000116	0.000345	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000114	0.000339	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000114	0.000339	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000114	0.000339	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000111	0.00033	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000107	0.000318	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000105	0.00031	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000101	0.000298	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.73e-05	0.000288	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.56e-05	0.000283	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.52e-05	0.000282	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.52e-05	0.000282	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	9.36e-05	0.000277	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	9.23e-05	0.000273	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	9.23e-05	0.000273	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	9.21e-05	0.000273	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	9.15e-05	0.000271	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	9.07e-05	0.000268	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.04e-05	0.000268	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.04e-05	0.000268	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	8.98e-05	0.000266	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.75e-05	0.000259	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.75e-05	0.000259	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	8.5e-05	0.000252	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	8.44e-05	0.00025	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	8.27e-05	0.000245	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.27e-05	0.000245	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.1e-05	0.00024	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.85e-05	0.000232	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	7.82e-05	0.000231	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	7.77e-05	0.00023	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	7.77e-05	0.00023	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.69e-05	0.000228	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	7.63e-05	0.000226	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	7.63e-05	0.000226	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	7.38e-05	0.000219	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	7.27e-05	0.000215	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.25e-05	0.000215	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.23e-05	0.000214	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—APOE—amyotrophic lateral sclerosis	7.2e-05	0.000213	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—APOE—amyotrophic lateral sclerosis	7.2e-05	0.000213	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	7.11e-05	0.00021	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.89e-05	0.000204	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.89e-05	0.000204	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	6.73e-05	0.000199	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	6.67e-05	0.000198	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.61e-05	0.000196	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	6.54e-05	0.000194	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	6.27e-05	0.000186	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	6.21e-05	0.000184	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.14e-05	0.000182	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	5.79e-05	0.000171	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	5.62e-05	0.000166	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.47e-05	0.000162	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.4e-05	0.00016	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	5.18e-05	0.000154	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	5.06e-05	0.00015	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.95e-05	0.000147	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.93e-05	0.000146	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.93e-05	0.000146	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	4.75e-05	0.000141	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	4.67e-05	0.000138	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	4.57e-05	0.000135	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	4.38e-05	0.00013	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.26e-05	0.000126	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.19e-05	0.000124	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.19e-05	0.000124	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.93e-05	0.000116	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.93e-05	0.000116	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.84e-05	0.000114	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.83e-05	0.000114	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.75e-05	0.000111	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.58e-05	0.000106	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.57e-05	0.000106	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.39e-05	0.0001	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.35e-05	9.93e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.23e-05	9.56e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.03e-05	8.98e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.94e-05	8.72e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.67e-05	7.91e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.55e-05	7.56e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.35e-05	6.95e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.3e-05	6.81e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.12e-05	6.28e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.06e-05	6.1e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.02e-05	5.98e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.02e-05	5.97e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.93e-05	5.72e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.89e-05	5.61e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.85e-05	5.49e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.75e-05	5.17e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.74e-05	5.16e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.73e-05	5.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	4.72e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.56e-05	4.61e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.53e-05	4.52e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.32e-05	3.92e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.32e-05	3.91e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.31e-05	3.88e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.07e-05	3.16e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.05e-05	3.1e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.36e-06	2.77e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.98e-06	2.66e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.6e-06	2.55e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	7.08e-06	2.1e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.85e-06	1.44e-05	CbGpPWpGaD
